Stifel reiterates Buy on Liberty Energy stock on power plans

Dr Douglas Williams is a veteran senior executive and board member for several biotech companies. During his time at Biogen, ZymoGenetics, Amgen Immunex and Seattle Genetics, he was involved in the development of several multibillion-dollar treatments, including Enbrel, Tecfidera and Spinraza. Matthew Partridge: The time and cost of clinical trials has been seen as one…

News release Today marks a major milestone in the modernisation of the UK’s payments landscape, with the Retail Payments Infrastructure Board (RPIB) launching a consultation on the future design of the UK’s next-generation retail payments infrastructure. The new infrastructure will provide a secure foundation for innovation, greater choice and more seamless payments, while supporting existing…

Sometimes JPMorgan executives receive emails from a colleague who signs off in all caps: JACK. JACK, however, isn’t one person. It’s the shared identity of John China and Andrew Kresse, who co-lead the bank’s Innovation Economy team for founders and venture capital firms. The nickname started as a practical solution, Kresse told Business Insider. “People…

Demand in Tier-2 housing markets has grown at a 14% CAGR over the past five years, but rising prices and affordability concerns are beginning to reshape where—and what—homebuyers should buy, according to a report by Crisil Intelligence.   The report says residential demand across 10 major Tier-2 cities expanded at a 14% compound…

Read More